MEDIUM confidence: 100% data completeness, but the composite (45) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20.5B— | $21.2B+3.2% | $25.5B+20.6% | $27.8B+9.1% | $27.7B-0.3% |
| EPS (dil.) | $-0.27— | $-0.61n/m | $1.91n/m | $2.98+56.0% | $2.60-12.8% |
| Free Cash Flow | $1.8B— | $1.1B-39.1% | $1.8B+64.7% | $2.1B+11.8% | $2.5B+23.5% |
| Gross Margin | 22.1% | 23.4%+1.3pp | 23.1%-0.3pp | 23.3%+0.2pp | 23.6%+0.3pp |
| Operating Margin | 6.4% | 8.9%+2.5pp | 10.4%+1.4pp | 12.2%+1.8pp | 12.8%+0.7pp |
| Net Margin | -1.1% | -2.8%-1.8pp | 7.6%+10.5pp | 10.7%+3.1pp | 9.3%-1.4pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 6.6%/yr (revenue basis).
Base free cash flow $2.1B (avg FY2023–FY2025; latest year $2.5B) · equity value $54.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$28.7M over 180 days (0 open-market buys, 7 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $72 avg across 9 analysts.
Buy-rated share 75% → 80% over ~3 months (+5pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $0.61 | $0.70 | +14.8% |
| Jul 2026 | $0.50 | $0.64 | +27.5% |
| Apr 2026 | $0.49 | $0.58 | +17.6% |
| Jan 2026 | $0.67 | $0.78 | +16.8% |
| Oct 2025 | $0.62 | $0.68 | +10.4% |
| Jul 2025 | $0.56 | $0.63 | +13.5% |
| Apr 2025 | $0.47 | $0.51 | +8.1% |
| Jan 2025 | $0.62 | $0.70 | +12.2% |
The QScore of 45 for Baker Hughes Company indicates a neutral outlook, with the stock's value and risk profiles being its strongest aspects. The value category scores high on the back of reasonable multiples, including a P/E of 18.7. In contrast, momentum and profitability scores drag down the overall QScore, due to a decline in recent price performance and moderate return on equity of 14.8%. The long-term and short-term scores are relatively aligned, suggesting a consistent view of the stock's fundamentals.